| Pharmaceutical Modulation of the Renin Angiotensin Aldosterone System for Stroke Prevention: A Review of Experimental and Clinical Evidence. | |
| | |
MedLine Citation:
|
PMID: 21632010 Owner: NLM Status: Publisher |
Abstract/OtherAbstract:
|
The renin angiotensin aldosterone system (RAAS) has been implicated in the pathogenesis of cerebrovascular diseases. During the past three decades, RAAS has gained attention as an important therapeutic target in cardiovascular medicine. Modulation of the RAAS for primary and secondary stroke prevention seems an appealing strategy. Several experimental studies have showed that pre-treatment with RAAS inhibitors prior to the initiation of ischemia exerts favorable effects on infarct volume, brain edema, and cerebral blood flow in the marginal zone. Furthermore, the activation of angiotensin receptor type 2 has been associated with neuroprotective effects. Accumulating evidence based on recent clinical trials indicate that blockade of RAAS has a potential role in stroke prevention. This review summarizes the pathophysiological aspects of brain RAAS and its constituents, presents experimental data on the neuroprotective actions of RAAS inhibitors and available evidence regarding their effects on stroke risk, and discuss future directions for research. |
| | |
Authors:
|
Elisavet Moutzouri; George Ntaios; Moses Elisaf; Haralampos J Milionis |
Publication Detail:
|
Type: JOURNAL ARTICLE Date: 2010-11-1 |
Journal Detail:
|
Title: CNS spectrums Volume: - ISSN: 1092-8529 ISO Abbreviation: - Publication Date: 2010 Nov |
Date Detail:
|
Created Date: 2011-6-2 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 9702877 Medline TA: CNS Spectr Country: - |
Other Details:
|
Languages: ENG Pagination: - Citation Subset: - |
Affiliation:
|
University of Ioannina School of Medicine. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: A Second Case Report of Lleuprolide Acetate for Depot Suspension-Induced Mania.
Next Document: Topiramate Augmentation in Resistant OCD: A Double-Blind Placebo-Controlled Clinical Trial.